Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
Non-small Cell Lung Cancer

About this trial
This is an interventional treatment trial for Non-small Cell Lung Cancer focused on measuring NSCLC, Targretin, Retinoid, Bexarotene
Eligibility Criteria
Patients must have: Pathologic (histologic or cytologic) confirmation of NSCLC Stage IIIB with malignant pleural effusion or Stage IV disease At least one measurable or evaluable NSCLC lesion that has not been previously irradiated unless radiation therapy was more than three weeks prior to entry in the study and the lesion has been shown to have progressed subsequent to the radiation therapy ECOG performance status 0 or 1 Adequate organ system function Fasting serum triglycerides that are within the age-adjusted normal range (or normalized with appropriate intervention such as antilipid therapy prior to the initiation of Targretin capsule therapy). Patients must be able to complete at least four cycles of combination chemotherapy (i.e., approximately four months) Patients must not have had: Brain metastasis Prior chemotherapy for NSCLC Prior platinum-based chemotherapy for any indication
Sites / Locations
- Montgomery Cancer Center, L.L.C.
- Arizona Clinical Research Center, Inc.
- Bay Area Cancer Research Group, LLC
- Compassionate Cancer Care Medical Group, Inc.
- Pacific Coast Hematology/Oncology Medical Group, Inc.
- California Cancer Care, Inc.
- Coast Hematology and Oncology Associates
- Metropolitan Hematology/Oncology Medical Group
- Sant P. Chawla, Inc.
- UCLA Medical Center
- Sutter Gould Medical Foundation
- Medical Oncology Care Associates
- Southern California Kaiser Permanente Medical Group
- Sharp Health Care
- UCSF/Mount Zion Comprehensive Cancer Center
- Medical Group of North County, Inc., San Diego Cancer Center
- Rocky Mountain Cancer Centers - Midtown
- Eastern Connecticut Hematology & Oncology
- Georgetown University Hospital
- Washington Cancer Institute
- Comprehensive Cancer Care Specialists of Boca Raton
- University of Florida/Jacksonville
- Watson Clinic
- Oncology and Radiation Associates
- Florida Cancer Institute
- Florida Oncology Associates
- Cancer Centers of Florida, P.A.
- South Florida Oncology & Hematology Consultants
- Medical Oncology Associates of Augusta
- Georgia Oncology Partners Research & Education Foundation
- St. Luke's/Mountain State Tumor Institute (MSTI)
- Weiss Memorial Hospital
- Northwest Oncology and Hematology, SC
- Lutheran General Cancer Care Center
- Oncology/Hematology Associates of Central Illinois, P.C.
- Hematology Oncology Assoc. of Illinois
- Central Indiana Cancer Centers
- Cancer Care Center
- Michiana Hematology-Oncology
- Kansas City Oncology and Hematology Group, Kansas City Cancer Centers
- Drs. Carroll, Sheth, and Raghavan
- Southwest Oncology Associates
- APMC
- Louisiana State University Health Sciences Center
- Tulane University Health Sciences Center
- Mercy Medical Center
- Chesapeake Oncology-Hematology Associates
- Associates in Oncology/Hematology PC
- Berkshire Hematology Oncology, PC
- University of Michigan Medical Center
- Providence Cancer Institute
- St. Lukes Hospital
- Minnesota Oncology Hematology, P.A.
- Missouri Cancer Associates
- Hematology Oncology Centers of the Northern Rockies
- Montana Cancer & Infectious Disease Specialists
- Cancer and Blood Specialists of Nevada
- Nevada Cancer Center
- Dartmouth-Hitchcock Medical Center
- Orange Medical Group
- VA New Jersey Health Care System
- Hematology-Oncology Associates of Northern NJ, PA
- Somerset Hematology Oncology Associates
- University of Medicine & Dentistry of NJ, School of Osteopathic Medicine
- Overlook Oncology Center
- San Juan Oncology Associates
- New York Oncology Hematology, P.C., Capital District Hematology Oncology Associates
- Erie Medical Center
- Roswell Park Cancer Institute
- Arena Oncology Associates
- Cancer Institute of Long Island, Inc.
- Cancer Research of Long Island, Inc.
- Broome Oncology, LLC
- New York Presbyterian Hospital, Weill Medical College of Cornell University
- Columbia Presbyterian Medical Center
- VA Medical Center
- New York Oncology Hematology, P.C., Riverview Cancer Care Medical Associates
- South Shore Hematology Oncology Associates, PC
- Raleigh Hematology Oncology Clinic
- Northwest Carolina Oncology and Hematology, P.A.
- Nashat Y. Gabrail, MD, Inc.
- University of Cincinnati, Barrett Cancer Center
- Columbus Community Clinical Oncology Program
- Dayton Oncology/Hematology Consultants
- University of Oklahoma Health Sciences Center
- Cancer Care Associates - Mercy Campus
- Cancer Care Associates
- Oncology/Hematology, Kaiser Permanente Northwest
- Oncology Hematology of Lehigh Valley, PC
- Medical Oncology Associates of Wyoming Valley, PC
- Charleston Hematology Oncology P.A.
- Liberty Hematology/Oncology
- WJB Dorn VA Medical Center
- Cancer Centers of the Carolinas
- Santee Hematology/Oncology
- Thompson Cancer Survival Center
- Boston Baskin Cancer Group
- Texas Oncology, P.A.
- South Austin Cancer Center
- Lone Star Oncology Consultants, P.A.
- Cancer Specialists of South Texas, PA
- Texas Cancer Center at Medical City
- Texas Oncology, P.A.
- Texas Oncology, P.A.
- Texas Oncology, P.A.
- University of Texas, MD Anderson Cancer Center
- Allison Cancer Center
- West Texas Cancer Center
- Hope Oncology
- Hematology & Oncology Associates of South Texas
- Tyler Cancer Center
- Texoma Cancer Center
- Utah Cancer Specialists
- Arlington Fairfax Hematology Oncology
- Hematology Oncology Patient Enterprises, Center for Cancer Care
- Danville Hematology & Oncology, Inc.
- Virginia Oncology Associates
- Stark MD, PC
- Virginia Cancer Institute
- Yakima Regional Cancer Care Center, Internal Medicine Associates of Yakima, Inc.
- Morgantown Internal Medicine Group
- Allgemeines offentliches Krankenhaus der barmherzigen Schwestern vom Heiligen Kreuz Pneumologie
- Sozialmedizinisches Zentrum
- Kaiser-Franz-Josef-Spital
- Algoma Regional Cancer Program - Sault Area Hospital
- Humber River Regional Hospital
- S.M.B.D. Jewish General Hospital
- Centre Hospitalier du Pays d'Aix
- Centre Hospitalier General de la Region Annecienne
- Centre Hospitalier d'Antibes-Juan-Les-Pins
- CHRU Hopital de Bois Guillaume
- DOP International
- Hopital de Draguignan
- Centre Hospitalier General
- Hopital du Cluzeau
- CHU Hopital St. Marguerite
- Centre Regional de Lutte contre le Cancer (CRLC), Val d'Aurelle-Paul Lamarque
- Hopital Saint Antoine
- CHU - Hopital Nord
- Hopital Saint Anne
- Service de Pneumology, Hopital Adulte de Brabois
- Centre Hospitalier
- Dept. of Internal Medicine, St. Nikolaus-Stiftshospital Andernach
- Aesklepios-Fachkliniken Muchen-Gauting
- Krankenhaus GroBhansdorf, Zentrum fur Pneumologie und Thoraxchirurgie
- Ludwig-Maximilians Universitat Munchen
- Charite Universitatsklinikum der Humboldt-Universitat zu Berlin
- Hospital Provincial de Castellon
- Hospital Clinico San Carlos
- Hospital Universitario Doctor Peset
- Hospital Universitario La Fe Servicio de Oncologia
- Hospital Arnau de Villanova, Servicio de Oncologia
- Hospital Clinico Universitario, Servicio Hematologia y Oncologia
- Hospital de Sagunto Servicio de Oncologia
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
bexarotene with carboplatin and paclitaxel
carboplatin and paclitaxel